Bausch & Lomb Inc. (BOL)

Had a misstep on a contact lens solution and the stock dropped to the mid-$40's. He bought at that level, because even if all of their contact lens solution went to zero, they still had other businesses. Recent rumours have driven the stock up to $60.

Have been under investigation by the FCC. Also had some product defect.

Has never been a big fan of this company. Believes they had to restate some earnings which is what caused the stock price to dip.

Has gone through a transition. Was suffering a few years ago when it lost its momentum, R&D lagged. Can see some growth opportunity in their new lens. New president has shaken down the company, cut costs and re-invigorated their R&D. Has exceeded expectations for 13 quarters.